Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

A synthetic hexapeptide that stimulates growth hormone secretion by mimicking ghrelin and binding to GHS receptors in the pituitary gland.

Quick Stats
Studies 702
Trials 0
Formula C46H56N12O6
Clear All
Utility 4
pubmed May 9, 2015

Ghrelin signaling in the ventral tegmental area mediates both reward-based feeding and fasting-induced hyperphagia on high-fat diet.

Wei. X J XJ; Sun. B B; Chen. K K; Lv. B B; Luo. X X; Yan. J Q JQ

Injecting ghrelin (or using a ghrelin‑like peptide such as GHRP‑6) directly into a brain area called the ventral tegmental area makes rats eat a lot more high‑fat food, even when they’re not hungry, and it adds extra weight. The same boost happens after a long fast, and both effects can be stopped by a ghrelin‑receptor blocker (D‑Lys3‑GHRP‑6).

Utility 4
pubmed Mar 3, 2012

Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in mice.

Xu. G G; Wang. Z Z; Li. Y Y; Li. Z Z; Tang. H H; Zhao. J J; Xiang. X X; Ding. L L; Ma. L L; Yuan. F...

The study shows that the hormone ghrelin is partly responsible for the blood‑sugar problems caused by rapamycin in mice. When the ghrelin receptor was blocked, rapamycin no longer messed up glucose control. This means that the way rapamycin hurts insulin sensitivity goes through ghrelin and its effects on muscle glucose transport.

Utility 4
pubmed Aug 19, 2011

Motivation to obtain preferred foods is enhanced by ghrelin in the ventral tegmental area.

King. S J SJ; Isaacs. A M AM; O'Farrell. E E; Abizaid. A A

Injecting ghrelin (or its secretagogue GHRP‑6) directly into the brain area that controls reward (the VTA) makes rats eat more, especially tasty high‑fat foods, and they work harder to get those foods even when they aren't hungry. Blocking the same receptor does the opposite, cutting down on high‑fat intake and weight gain.

Utility 4
pubmed Mar 2, 2011

Ghrelin inhibits visceral afferent activation of catecholamine neurons in the solitary tract nucleus.

Cui. Ran Ji RJ; Li. Xiaojun X; Appleyard. Suzanne M SM

The study shows that ghrelin (the hormone that GHRP‑6 mimics) suppresses activity of certain brainstem neurons that normally help control eating. It does this by lowering the amount of glutamate signals they receive, especially when you’ve been fasting for many hours. In simple terms, ghrelin makes you hungrier by turning down a brain circuit that would otherwise signal satiety, and this effect gets stronger after a long fast.

Utility 4
pubmed 2008

Fast conventional Fmoc solid-phase peptide synthesis with HCTU.

Hood. Christina A CA; Fuentes. German G; Patel. Hirendra H; Page. Karen K; Menakuru. Mahendra M; Par...

Researchers showed that a cheap, non‑toxic chemical called HCTU can make the lab process for building peptides like GHRP‑6 much faster. By swapping in HCTU, the steps that normally take many minutes can be done in under five minutes, cutting total production time by up to two days without lowering the quality of the peptide.

Utility 4
pubmed Jun 1, 2005

Central responsiveness to a ghrelin mimetic (GHRP-6) is rapidly altered by acute changes in nutritional status in rats.

Tung. Y C L YC; Hewson. A K AK; Carter. R N RN; Dickson. S L SL

The study shows that the brain reacts much more strongly to the ghrelin‑like peptide GHRP‑6 when you’re fasting, but just two hours of eating – even just sugar – drops that response back down. This change happens even though hormones like leptin and insulin stay low, so the key factor seems to be the rise in blood sugar after a meal.

Utility 4
pubmed 2004

Growth hormone response to GHRH + GHRP-6 in type 2 diabetes during euglycemic and hyperglycemic clamp.

Micic. Dragan D; Kendereski. Aleksandra A; Sumarac-Dumanovic. Mirjana M; Cvijovic. Goran G; Popovic....

In men with type 2 diabetes, giving the GH‑releasing combo GHRH + GHRP‑6 while blood sugar is high (like after a big carb load) blunts the growth‑hormone surge compared to when blood sugar is normal. So, the glucose level around the time you take GHRP‑6 matters for how much GH you’ll actually get.

Utility 4
pubmed 2004

Glucocorticoid-dependent stimulation of adiposity and appetite by a ghrelin mimetic in the rat.

Tung. Y L YL; Hewson. A K AK; Dickson. S L SL

In rats, daily injections of the ghrelin‑like peptide GHRP‑6 made the animals gain weight. The weight gain happened even without the stress hormone cortisol, but the extra body fat only appeared when normal cortisol levels were present. GHRP‑6 also made the rats eat more, but that appetite boost only occurred if cortisol was around.

Utility 4
pubmed Apr 6, 2005

Development of growth hormone secretagogues.

Smith. Roy G RG

Growth‑hormone secretagogues like GHRP‑6 can boost the body’s natural GH release, giving older people a hormone pattern similar to a young adult. This rise in GH leads to more bone density, lean muscle, modest strength gains, faster fracture healing, and even better immune‑system (thymus) function in animal studies.

Utility 4
pubmed Nov 1, 2000

Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats.

Hewson. A K AK; Dickson. S L SL

The study shows that giving ghrelin or the synthetic peptide GHRP‑6 to rats triggers activity in brain cells that control hunger and growth hormone, and this effect is much stronger when the animals are fasted. In simple terms, GHRP‑6 works not just in the body but also directly in the brain, and it does its best job when you take it on an empty stomach.

Utility 4
pubmed 1999

Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.

Micić. D D; Macut. D D; Popović. V V; Kendereski. A A; Sumarac-Dumanović. M M; Zor...

In people with type‑2 diabetes, a peptide called GHRP‑6 still triggers a strong growth‑hormone (GH) surge, no matter if they’re normal‑weight or overweight. The usual GH‑releasing hormone (GHRH) works well in normal‑weight diabetics but is much weaker in overweight ones. When GHRP‑6 and GHRH are given together, they boost GH even more, though the peak is still lower in overweight patients.

Utility 4
pubmed 2001

Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin.

Tannenbaum. G S GS; Bowers. C Y CY

The study shows that GHRP‑6 makes the pituitary release growth hormone by working through the body’s natural GHRH system, not by blocking somatostatin. Its effect depends on the timing of the body’s GH pulses, and if GHRH is blocked, GHRP‑6 stops working. This means GHRP‑6 works best when the GHRH pathway is active and may be more effective if paired with GHRH‑like compounds or timed to natural GH peaks.

Utility 4
pubmed 1995

Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level.

Popovic. V V; Damjanovic. S S; Micic. D D; Djurovic. M M; Dieguez. C C; Casanueva. F F FF

The study shows that GHRP-6 triggers a strong release of growth hormone (GH) by acting mainly on the brain (hypothalamus). In healthy people it works even better when paired with a GH‑releasing hormone (GHRH) drug, creating a big boost in GH. However, in patients whose hypothalamus‑pituitary connection is broken, GHRP-6 barely works, confirming its hypothalamic site of action.

Utility 4
pubmed 2001

GH-releasing peptide-6 overcomes refractoriness of somatotropes to GHRH after feeding.

McMahon. C D CD; Chapin. L T LT; Radcliff. R P RP; Lookingland. K J KJ; Tucker. H A HA

After you eat, your pituitary cells that make growth hormone (GH) become less responsive to the usual signal (GHRH). This study shows that giving the synthetic peptide GHRP‑6 can restore and even boost that response, especially when used together with a low dose of GHRH. GHRP‑6 works both by directly stimulating the pituitary and by prompting the brain to release more GHRH, without affecting the GH‑blocking hormone somatostatin.

Utility 4
pubmed Jan 1, 1998

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.

Popovic. V V; Simic. M M; Ilic. L L; Micic. D D; Damjanovic. S S; Djurovic. M M; Obradovic. S S; Die...

In people with a normal or only mildly affected pituitary (like healthy folks or those with tiny prolactin‑secreting tumors), GHRP‑6 reliably raises growth hormone levels, and when you add a GHRH peptide the boost is much bigger. Big pituitary tumors blunt this effect, but shrinking the tumor with bromocriptine can restore the response. GHRP‑6 does not raise prolactin in any group.

Utility 4
pubmed Jun 1, 1995

Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.

Cordido. F F; Peñalva. A A; Peino. R R; Casanueva. F F FF; Dieguez. C C

Giving the peptide GHRP‑6 together with a growth‑hormone‑releasing hormone (GHRH) shot makes the body release a big burst of growth hormone, and this works even if you block somatostatin with pyridostigmine. In lean people the peak GH is about 75 ”g/L at 30 min, while in obese people the peak is roughly half that (≈42 ”g/L) and the overall GH exposure is lower. Adding pyridostigmine doesn’t boost the response any further.

Utility 4
pubmed 1997

Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat.

Bennett. P A PA; Thomas. G B GB; Howard. A D AD; Feighner. S D SD; van der Ploeg. L H LH; Smith. R G...

The study shows that the brain's growth‑hormone secretagogue receptor (GHS‑R) is controlled by the amount of growth hormone (GH) in the body: low GH levels boost the receptor, while giving GH lowers it. Importantly, giving the secretagogue peptide GHRP‑6 continuously did NOT change receptor levels, suggesting the body doesn’t quickly shut the receptor off with regular use.